Active Projects

Publications

Complete listing available on the NYU Health Sciences Library site.

Active Projects

• R01NS098772
  CRMP2, Mitochondria, and Huntington Disease
  (Multi-PI; only the direct costs allocated to Khanna are shown)
  4/1/17  2/28/22
  
  
• R01DA042852
  CRMP2, Nav1.7 Sodium Channel, and Chronic pain
  6/1/17  2/28/22
  
  
• R01NS120663
  Genetic and Pharmacological Validation of CRMP2 Phosphorylation as a Novel therapeutic target for Neuropathic Pain
  8/1/20  7/31/24
  
  
• R01NS120663-S1
  Sentrin Proteases, CRMP2 deSUMOylation, and Chronic Pain
  1/15/21  8/31/24
  
  
• R01NS120663-S2
  CRMP2 Phosphorylation: A Novel Target for Alzheimer’s Disease
  4/15/21  7/31/24
  
  
• R01NS119263
  Anti-CV2 Autoantibodies Unmask a CRMP5/GluN2B Pain Signaling Hub (co-I; only the direct costs allocated to Khanna are shown)
  1/1/20  12/21/25
  
  
• R01AT009716
  Green Light Therapy for Chronic Pain
  (co-I; PI: Ibrahim)
  7/16/18  5/31/23
  
  
• K08NS104272
  Mechanism of Intrathecal Contulakin-G Induced Analgesia Without Motor Block
  (co-I; PI: Patwardhan)
  7/15/18  4/30/23
  
  
• R01AT009716-S1
  Green Light Therapy for Improving Dementia in Mice Models of Alzheimer’s Disease
  (co-I; 10% of grant costs allocated to Khanna)
  3/1/21  2/28/22
  
  
• R01NS116694
  Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target
  (co-I; PI: Patwardhan)
  9/15/20  8/31/24
  
  
• R41CA257845
  Inhibition of CaVα-β Interaction with Orally Available Small Organic Molecules for Chronic Pain
  5/1/21  4/30/22
  
  
• R41NS122545
  Targeting the Neuropilin-1 Receptor (NRP-1)/VEGF-A Axis for Neuropathic Pain
  7/1/21  6/30/23
  
  
• 75N95019D00012
  Disease Model Characterization and Development of Assays to Evaluate and Measure Pain in a Porcine Model for Sickle Cell Disease
  (Subcontract)
  10/1/19  6/30/22
  
  
• CCXDP
  TAF1, T-Type channels, and X-linked Dystonia Parkinsonism, Collaborative Center for X-linked Dystonia Parkinsonism
  1/1/22  6/30/23
  
  
• GEMM Award
  A NaV1.7 Mouse Lacking the CRMP2-binding Domain: Examining Specificity of NaV1.7-CRMP2 Coupling and Testing If Pain Resolution Requires Endogenous Opioid Signaling
  7/1/20  6/30/21
  
  
• UA Venture Captial
  Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy
  7/1/21  6/30/23
  
  
• TLA Asset Development Award
  Blocking NRP-1 for the Treatment of Pain, Cancer and Prevention of Viral Entry
  5/1/21  4/30/23
  
  
• Cariplo foundation (Italy)
  The Crucial Role of HCN2 Channels in Inflammatory and Neuropathic Pain
  1/1/21  12/30/23